Compass Therapeutics, Inc.

NasdaqCM:CMPX Stock Report

Market Cap: US$152.7m

Compass Therapeutics Management

Management criteria checks 0/4

Compass Therapeutics' CEO is Tom Schuetz, appointed in May 2024, has a tenure of less than a year. total yearly compensation is $4.87M, comprised of 11.8% salary and 88.2% bonuses, including company stock and options. directly owns 3.82% of the company’s shares, worth $5.84M. The average tenure of the management team and the board of directors is 1 years and 2.4 years respectively.

Key information

Tom Schuetz

Chief executive officer

US$4.9m

Total compensation

CEO salary percentage11.8%
CEO tenureless than a year
CEO ownership3.8%
Management average tenureless than a year
Board average tenure2.4yrs

Recent management updates

Recent updates

We Think Compass Therapeutics (NASDAQ:CMPX) Can Afford To Drive Business Growth

Jun 05
We Think Compass Therapeutics (NASDAQ:CMPX) Can Afford To Drive Business Growth

We're Hopeful That Compass Therapeutics (NASDAQ:CMPX) Will Use Its Cash Wisely

Feb 13
We're Hopeful That Compass Therapeutics (NASDAQ:CMPX) Will Use Its Cash Wisely

Companies Like Compass Therapeutics (NASDAQ:CMPX) Are In A Position To Invest In Growth

Sep 20
Companies Like Compass Therapeutics (NASDAQ:CMPX) Are In A Position To Invest In Growth

Compass Therapeutics, Merck ink collaboration deal for early-stage cancer trial

Oct 11

CEO Compensation Analysis

How has Tom Schuetz's remuneration changed compared to Compass Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$45m

Dec 31 2023US$5mUS$575k

-US$42m

Sep 30 2023n/an/a

-US$41m

Jun 30 2023n/an/a

-US$43m

Mar 31 2023n/an/a

-US$40m

Dec 31 2022US$2mUS$550k

-US$39m

Sep 30 2022n/an/a

-US$41m

Jun 30 2022n/an/a

-US$35m

Mar 31 2022n/an/a

-US$82m

Dec 31 2021US$5mUS$4k

-US$82m

Sep 30 2021n/an/a

-US$78m

Jun 30 2021n/an/a

-US$81m

Mar 31 2021n/an/a

-US$31m

Dec 31 2020US$3mUS$4k

-US$29m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$27m

Mar 31 2020n/an/a

-US$30m

Dec 31 2019US$1mUS$400k

-US$35m

Compensation vs Market: Tom's total compensation ($USD4.87M) is above average for companies of similar size in the US market ($USD1.55M).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.

CEO

Tom Schuetz (63 yo)

less than a year

Tenure

US$4,873,206

Compensation

Dr. Thomas J. Schuetz, also known as Tom, M.D., Ph.D. was co-founded of Compass Therapeutics, Inc in 2014 until 2024 and He serves as its CEO since May 28, 2024. He also served as President since May 28, 2...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Schuetz
Chief Executive Officerless than a yearUS$4.87m3.82%
$ 5.8m
Vered Bisker-Leib
Senior Consultantless than a yearUS$4.07m0.56%
$ 856.1k
Neil Lerner
Vice President of Financeno datano datano data
Jonathan Anderman
VP, Head of Legal & Corporate Secretary2.8yrsno datano data
Anna Gifford
Communications Managerno datano datano data
Minori Rosales
Senior VP & Head of Clinical Development1.1yrsno datano data
Karin Herrera
VP & Head of Clinical Operations1.1yrsno datano data
James Kranz
VP and Head of Chemistry Manufacturing & Controlsless than a yearno datano data

1.0yrs

Average Tenure

59yo

Average Age

Experienced Management: CMPX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Carl Gordon
Independent Chairman9.4yrsUS$222.63k0%
$ 0
Daniel Von Hoff
Member of Clinical Advisory Board2.4yrsno datano data
Ellen Chiniara
Independent Director2.2yrsUS$163.42k0%
$ 0
Philip Ferneau
Independent Director9.4yrsUS$193.02k0%
$ 0
Richard Lindahl
Independent Director1.2yrsUS$147.92k0%
$ 0
Mary Gray
Independent Director2.2yrsUS$163.42k0%
$ 0
James Boylan
Independent Director1.6yrsUS$45.00k0%
$ 0
F. Hodi
Member of Clinical Advisory Board4.7yrsno datano data
Patricia LoRusso
Member of Clinical Advisory Board2.4yrsno datano data
Edward Chu
Member of Clinical Advisory Board2.4yrsno datano data
Richard Goldberg
Member of Clinical Advisory Board2.4yrsno datano data
Howard Hochster
Member of Clinical Advisory Board2.4yrsno datano data

2.4yrs

Average Tenure

61yo

Average Age

Experienced Board: CMPX's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.